Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...
The results jibe with earlier research showing that childhood obesity rates are steadily rising, even though food insecurity ...
The European Medicines Agency backed the use of Novo Nordisk's Wegovy in patients with an obesity-related heart condition, ...
Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.
Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...
Patients with cancer want information and advice early in the disease course about how to deal with the financial stressors ...
From doctors' offices to family gatherings, larger-bodied people report being bombarded with unsolicited advice about their ...
Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...
BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...
"When you have two-thirds plus of the active duty military force that's obese ... you know you've got a huge problem," ...